Active
KANEKA EUROGENTEC logo

KANEKA EUROGENTEC

Switched

BE0427348346

Rechtspersoon Public limited company 4 establishments

Rue du Bois St-Jean 5, 4102 Seraing Vervaardiging van overige farmaceutische producten eurogentec.com

Active for

41 year, 3 months

Financials

Financial year 2026

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Revenue

€ 49.4 million

▼ 27% vs 2025

Profit

Caution

€ -20.4 million

▲ 44% vs 2025

Debts

High

€ 115.3 million

▲ 10% vs 2025

KANEKA EUROGENTEC from Seraing, company number BE0427348346, closed financial year 2026 with a result of € -20.4 million after tax. For that financial year KANEKA EUROGENTEC recorded revenue of € 49.4 million and equity of € -4,334. Compared with financial year 2025, the result moved from € -36.3 million to € -20.4 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What happened at KANEKA EUROGENTEC?

What happened at KANEKA EUROGENTEC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Masaaki KIMURA stepped down as director. NBB
  • Mitsuaki KITANO stepped down as director. NBB
  • Masanobu SUGAWARA stepped down as director. NBB
  • Kan OKABE stepped down as director. NBB
  • Lieven JANSSENS stepped down as director. NBB
  • New annual accounts for financial year 2026: loss of € 20.4 million. Source: NBB ↗
  • Masaaki KIMURA became a director. NBB
  • Mitsuaki KITANO became a director. NBB

In short

From € 11.2 million profit in 2022 to € 20.4 million loss in 2026.

Paid € 6 million in corporate taxes since 2022.

Best year ever: 2023, with € 13.8 million profit.

Paid out € 18.2 million in dividends to the owners in total.

A new publication or filing at KANEKA EUROGENTEC? We notify you, reason included.

Follow KANEKA EUROGENTEC

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

KANEKA EUROGENTEC
EUROGENTEC PROTEOMICS GMBH 100%
EUROGENTEC NORTH AMERICA 100%
EUROGENTEC LTD 100%
EUROGENTEC NEDERLAND 100%
+3

It owns 100% of EUROGENTEC PROTEOMICS GMBH, 100% of EUROGENTEC NORTH AMERICA, 100% of EUROGENTEC LTD, 100% of EUROGENTEC NEDERLAND, 100% of EUROGENTEC FRANCE and 25% of THYMOLUX itself.

See the full network in the app

Directors

According to the 2026 annual accounts

Masanobu SUGAWARA

Director

since 2022 · until 2028

Kan OKABE

Director

since 2022 · until 2028

Lieven JANSSENS

Managing director

since 2022 · until 2028

Masaaki KIMURA

Director

since 2024 · until 2030

Mitsuaki KITANO

Director

since 2024 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Bois St-Jean 5

4102 Seraing

2.027.405.710

Rue du Bois St-Jean 14

4102 Seraing

Active since 1 October 1985

2.351.915.745

Rue du Bois St-Jean 23

4102 Seraing

Active since 1 July 2021

2.351.915.844

Rue dèl Rodje Cinse 98

4102 Seraing

Active since 30 October 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Amazon CloudFrontCookie ConsentFont AwesomeGoogle FontsGoogle Tag ManagerSlickStimulus

Hosting & Email

Email provider

Microsoft 365

Hosting

OVH, FR

Domain

Domain

eurogentec.com

Registered

1999-01-05

Registrar

Network Solutions, LLC

Expires

2027-01-05

Website info

HTTPS Ja
Languages EN

Features

Webshop Blog Jobs Client portal Ads Contact page

Security

HTTPS
SPF
DMARC

Details

Company number
0427.348.346
VAT number
BE 0427.348.346
Registered office
Rue du Bois St-Jean 5, 4102 Seraing
Names & denominations
KANEKA EUROGENTEC
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
18 May 1985
Peppol
Active · Active since 11 Dec 2025
Activities · NACE

Vervaardiging van overige farmaceutische producten

Vervaardiging van overige farmaceutische preparaten

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Vervaardiging van andere chemische producten, neg

Vervaardiging van farmaceutische grondstoffen

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What is the enterprise number of KANEKA EUROGENTEC?
The enterprise number of KANEKA EUROGENTEC is BE0427348346.
What is the address of KANEKA EUROGENTEC?
The registered office of KANEKA EUROGENTEC is located at Rue du Bois St-Jean 5, 4102 Seraing.
When was KANEKA EUROGENTEC founded?
KANEKA EUROGENTEC was founded on 18 May 1985.
What is the main activity of KANEKA EUROGENTEC?
The main activity of KANEKA EUROGENTEC is "Vervaardiging van overige farmaceutische producten" (NACE code 21209).
Does KANEKA EUROGENTEC have a website?
Yes, KANEKA EUROGENTEC has a website at eurogentec.com.
Does KANEKA EUROGENTEC have an online shop?
Yes, KANEKA EUROGENTEC has an online shop.
Is KANEKA EUROGENTEC active on social media?
Yes, KANEKA EUROGENTEC is active on Twitter, Facebook, Linkedin.
How much profit did KANEKA EUROGENTEC make in 2026?
KANEKA EUROGENTEC recorded a loss after taxes of € 20,394,259 in financial year 2026.
What is the revenue of KANEKA EUROGENTEC?
In its most recent annual accounts (2026), KANEKA EUROGENTEC reported revenue of € 49,421,165.
How many employees does KANEKA EUROGENTEC have?
According to the 2026 annual accounts, KANEKA EUROGENTEC has 379.2 full-time equivalents (FTE).
Where can I find the annual accounts of KANEKA EUROGENTEC?
KANEKA EUROGENTEC files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of KANEKA EUROGENTEC?
According to the 2026 annual accounts, the directors of KANEKA EUROGENTEC are: Masanobu SUGAWARA, Kan OKABE, Lieven JANSSENS, Masaaki KIMURA, Mitsuaki KITANO.
Who owns KANEKA EUROGENTEC?
It owns 100% of EUROGENTEC PROTEOMICS GMBH, 100% of EUROGENTEC NORTH AMERICA, 100% of EUROGENTEC LTD, 100% of EUROGENTEC NEDERLAND, 100% of EUROGENTEC FRANCE and 25% of THYMOLUX itself.